Japanese Convenience Stores To Sell OTCs

21 March 1997

As a result of Japan's speeded-up deregulation process, a governmentdecision has been reached to allow convenience stores to sell certain kinds of medicines from April 1, 1998, a full year ahead of schedule. There are well over 48,000 convenience stores in Japan, with 7-Eleven group shops alone accounting for 6,700 of these.

Non-drugstore retailers, such as convenience stores, are not at present allowed to sell medicines due to a law requiring certain equipment for testing and inspection to be on the promises. However, in line with proposals by the Administrative Reform Commission, the Ministry of Health and Welfare has decided to do away with this requirement and to allow vitamin products, health drinks and certain other over-the-counter medicines to be made available through these outlets.

Ministry officials also agreed with the Management and Coordination Agency to review the system for setting price standards for medicines during fiscal 1997, which begins on April 1. The present system has been much criticized for its lack of transparency.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight